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Whole-body MRI: comprehensive evaluation on a 48-channel
3T MRI system in less than 40 minutes. Preliminary results*
RM de corpo inteiro: avaliação de protocolo em equipamento 3T com 48 canais em menos de 40 minutos.
Resultados preliminares
Mateus de Andrade Hernandes1, Richard C. Semelka2, Jorge Elias Júnior3, Saraporn Bamrungchart1,
Brian M. Dale4, Clifton Stallings5
Objective: To evaluate a comprehensive MRI protocol that investigates for cancer, vascular disease, and degenerative/
inflammatory disease from the head to the pelvis in less than 40 minutes on a new generation 48-channel 3T system.
Materials and Methods: All MR studies were performed on a 48-channel 3T MR scanner. A 20-channel head/neck
coil, two 18-channel body arrays, and a 32-channel spine array were employed. A total of 4 healthy individuals were
studied. The designed protocol included a combination of single-shot T2-weighted sequences, T1-weighted 3D gradient-
echo pre- and post-gadolinium. All images were retrospectively evaluated by two radiologists independently for overall
image quality. Results: The image quality for cancer was rated as excellent in the liver, pancreas, kidneys, lungs, pelvic
organs, and brain, and rated as fair in the colon and breast. For vascular diseases ratings were excellent in the aorta,
major branch vessel origins, inferior vena cava, portal and hepatic veins, rated as good in pulmonary arteries, and as poor
in the coronary arteries. For degenerative/inflammatory diseases ratings were excellent in the brain, liver and pancreas.
The inter-observer agreement was excellent. Conclusion: A comprehensive and time efficient screening for important
categories of disease processes may be achieved with high quality imaging in a new generation 48-channel 3T system.
Keywords: Whole-body MRI; Screening; Protocol; Preliminary results; 3 tesla.
Objetivo: Avaliar protocolo de RM para investigação de neoplasia, doenças vascular e degenerativa/inflamatória da
cabeça à pelve em menos de 40 minutos em equipamento 3T com 48 canais. Materiais e Métodos: Todos os exa-
mes foram realizados em equipamento 3T com 48 canais. Foram utilizadas bobinas de cabeça/pescoço (20 canais),
duas de corpo interligadas (18 canais) e uma de coluna (32 canais). Quatro voluntários saudáveis foram estudados.
Foi utilizado protocolo com sequências single shot pesadas em T2 e gradiente-eco 3D pesadas em T1 pré e pós-ga-
dolínio. Todas as imagens foram avaliadas quanto à qualidade, retrospectivamente, por dois radiologistas de forma
independente. Resultados: A qualidade da imagem foi classificada como excelente para o fígado, pâncreas, rins,
pulmões, órgãos pélvicos e encéfalo, e como adequada para cólon e mamas. Para as doenças vasculares as imagens
foram classificadas como excelentes para aorta e seus ramos principais, veia cava inferior, veias porta e hepáticas,
como boas para artérias pulmonares, e como inadequadas para coronárias. As classificações para doenças degene-
rativas/inflamatórias foram excelente no encéfalo, fígado e pâncreas. A concordância interobservador foi excelente.
Conclusão: Um rastreamento abrangente de importantes categorias de doenças pode ser realizado utilizando ima-
gens de alta qualidade obtidas em uma nova geração de equipamento 3T com 48 canais.
Unitermos: RM de corpo inteiro; Screening; Protocolo; Resultados preliminares; 3 tesla.
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Since its early description, whole-body
MRI has been considered a promising tool
for detection of disease. The greater intrin-
sic soft tissue contrast resolution and
greater sensitivity for intravenous contrast
of MRI over CT, allied with the lack of
radiation exposure and safer contrast ma-
terials, make MRI an excellent choice for
screening purposes. However, whole-body
MRI with surface coils and conventional
sequences is time consuming and costly.
The introduction of faster gradient MRI
systems, parallel acquisition strategies, re-
INTRODUCTION
The concept of whole-body MRI is not
new, however its clinical use has been lim-
ited in the past mainly because of its long
scanning time and/or poor image quality.
Additionally, there has been progress in the
development of other whole-body imaging
modalities, such as whole-body CT, PET,
and PET/CT. Recently, however, an increas-
ing awareness of the risks of ionizing radia-
tion exposure has encouraged the investiga-
tion of alternative imaging techniques(1,2).
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mote control of table motion, together with
interconnection of multiple multichannel
phased-array coils, has improved the spa-
tial resolution and speed of data acquisi-
tion, and rendered whole-body MRI diag-
nostically accurate and fast(3–5). It remains
important, however, to select the diseases
that are of interest for screening because it
is still not practicable to study the entire
body with dedicated high-spatial-resolu-
tion MR sequences due to time constraints.
Other authors have shown the useful-
ness of whole-body MRI to screen for a
variety of diseases, mostly evaluating ves-
sels with MR angiography technique, and
in the detection of metastatic cancer(6–12).
These strategies, however, do not evaluate
the whole body in a comprehensive fash-
ion for the majority of important diseases,
including cancer, vascular and degenera-
tive/inflammatory diseases.
Therefore, the aim of our study was to
prospectively evaluate the feasibility of a
comprehensive, less than 40 minutes,
whole-body MRI protocol, employing a
combination of sequences to evaluate a full
range of disease processes on a 48-channel
3.0T MR system, with the injection of in-
travenous gadolinium-based contrast and
multiple interconnected regional coils. We
describe the strengths of this approach, and
the areas where further work is necessary.
MATERIALS AND METHODS
Patients
The study population was comprised of
4 individuals (3 males and 1 female; age
range of 28–50 years; mean age of 40 years).
Signed informed consent was obtained in
accordance with the Institutional Review
Board requirements. All subjects were
healthy, worried well individuals undergo-
ing screening procedure.
Imaging technique
All MR studies were performed on a
new generation 3T MR scanner equipped
with 48 channels (Skyra; Siemens, Malvern,
PA). A 20-channel head/neck coil, two 18-
channel body arrays, and a 32-channel
spine array were employed in all subjects.
Patients were supine and placed head
first in the scanner. Sequences employed
were either breath hold or breathing inde-
pendent.
The protocol was designed to screen for
cancer, vascular disease and inflammatory/
degenerative diseases. A combination of
single-shot echo-train spin-echo (SS-ETSE)
T2-weighted sequences, three-dimensional
gradient-echo (3D-GE) T1-weighted pre-
and post-gadolinium sequences, with fat-
suppression (FS) images, and a fluid at-
tenuated inversion recovery (FLAIR) se-
quence (head only) were employed. Four
regional stations were acquired in the fol-
lowing order: abdomen, chest, pelvis, head
and neck. The sequences parameters and
the order of sequence acquisition in the
four stations are showed in Table 1.
The abdominal images were acquired
before and after intravenous administration
of 0,1 mmol/kg of gadobenate dimeglumine
(MultiHance; Bracco Diagnostics Inc.,
Table 1 Whole-body MRI protocol.
Region
Abdomen
Chest
Pelvis
Head and neck
Sequence
Localizer
T2 SS-ETSE
T1 3D GE FS
T2 SS-ETSE FS
T1 3D GE Dixon
T1 3D GE FS pre
T1 3D GE FS arterial
T1 3D GE FS venous
T1 3D GE FS interstitial
T1 3D GE FS
Localizer
T1 3D GE FS
T1 3D GE FS
T2 SS-ETSE FS
T2 SS-ETSE FS
Localizer
T1 3D GE FS
T1 3D GE FS
T2 SS-ETSE FS
T2 SS-ETSE
Localizer
T1 3D GE FS (head)
T1 3D GE FS (head and neck)
T2 SS-ETSE FS (head and neck)
FLAIR (head)
Plane
Coronal
Coronal
Axial
Axial
Axial
Axial
Axial
Axial
Coronal
Coronal
Axial
Axial
Coronal
Coronal
Axial
Axial
Sagittal
Axial
Sagittal
Sagittal
Axial
TR
(ms)
1600
4.3
1600
4.5
4.3
4.3
4.3
4.3
4.3
4.3
4.3
1600
1600
4.3
4.3
1600
1600
4.3
4.3
1600
9000
TE
(ms)
95
1.8
95
1.3
1.9
1.9
1.9
1.9
1.8
1.8
1.9
95
95
1.8
1.9
95
95
2.0
2.0
96
81
Flip
(degrees)
130
9
160
9
9
9
9
9
9
9
9
160
130
9
9
160
160
9
9
160
150
Slice thickness
(mm)
5.0
1.5
7.0
3.0
3.0
3.0
3.0
3.0
1.5
1.5
3.0
5.0
5.0
1.5
2.0
5.0
5.0
1.0
1.0
3.0
4.0
FOV
(mm)
450
450
380
380
380
380
380
380
450
450
380
380
450
450
380
380
380
280
380
400
220
Matrix
(pixels)
290 × 320
260 × 320
320 × 240
320 × 250
320 × 260
320 × 260
320 × 260
320 × 260
260 × 320
260 × 320
320 × 260
320 × 240
290 × 320
260 × 320
320 × 260
320 × 240
240 × 320
260 × 320
312 × 384
240 × 320
310 × 320
 20 ml of gadobenate dimeglumine, intravenous injection at 2 ml/sec.
T2 SS-ETSE, T2-weighted single-shot echo-train spin-echo; T1 3D GE, T1-weighted three-dimensional gradient-echo; FS, fat-suppressed; FLAIR, fluid attenuated inversion
recovery.
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Princeton, NJ, USA). Abdominal post-con-
trast images were acquired during the he-
patic arterial dominant phase, portal venous
phase and hepatic interstitial phase(13). All
sequences of other stations were acquired
after intravenous contrast had been admin-
istered.
Image analysis
All images of the different anatomical
regions were retrospectively evaluated by
two radiologists, with 16 years and greater
than 20 years experience with MRI, respec-
tively. Both readers independently re-
viewed all exams evaluating the image
quality and the ability of this MRI tech-
nique to evaluate mass lesions, metastases
or vascular disease of major vessels. The
MR image evaluation included: 1) the over-
all image quality; and 2) comparative as-
sessment of image quality with a priori
knowledge of gold standard diagnostic
imaging studies. This approach is similar
to the approach used by several groups to
assess image quality, both for similar appli-
cations and more generally(7,9,14–17).
A checklist (Table 2) was created for the
overall image quality assessment. Follow-
ing this checklist, image quality of each
station were subjectively graded in terms of
diagnostic evaluation for cancer, vascular
and degenerative/inflammatory diseases
using a 4-point scale, as follows: 1 = poor;
2 = fair; 3 = good; 4 = excellent.
For the comparative assessment rating,
the diagnostic image quality of each station
was compared with the diagnostic quality
of optimal imaging studies on MR (abdo-
men, pelvis, head and neck) or CT (chest)
based on the previous knowledge of two
experienced radiologists. Each set of im-
ages was then subjectively graded using
another 4-point scale, where a score of 1 =
poor quality, not diagnostic, a score of 2 =
moderately inferior but still adequate qual-
ity, a score of 3 = slightly inferior but ad-
equate quality, and a score of 4 = equiva-
lent to optimal quality diagnostic studies.
Kappa (κ) analysis was performed to de-
termine the extent of agreement between
the two readers. The level of agreement was
defined by κ values as follows: < 0, no
agreement; 0–0.40, poor agreement; 0.41–
0.75, good agreement; and 0.76–1.0, excel-
lent agreement.
RESULTS
None of the subjects in this study had a
prior history of malignancy. Abnormalities
detected included liver cysts (1 subject),
kidney cysts (2 subjects), degenerative disc
disease (2 subjects) and benign prostatic
hyperplasia (1 subject). No subject demon-
strated lung/chest, brain abnormalities or
major vascular disease, nor did any dem-
onstrate a malignancy.
The “in bore” magnet time of studies
ranged from 30 to 44 minutes (mean, 38
minutes).
The image quality for cancer was rated
as excellent in the brain, lungs, liver, pan-
creas, kidneys, pelvic organs and rectum,
rated as good in bone structures and rated
as fair in the esophagus, small bowel and
colon, and breast. For vascular diseases
ratings were excellent in the aorta and
major branches origins, iliac vessels, supe-
rior/inferior vena cava, hepatic portal sys-
tem, hepatic veins and renal veins, and
rated as good in pulmonary arteries (suc-
cessful for the main vessels and at least
second order branches), carotid arteries and
intracranial vessels, but poor for the coro-
nary arteries. For degenerative/inflamma-
tory disease, ratings were excellent in the
brain, liver and pancreas, good in bone
structures (spine, hip joints and shoulder
joints), and rated as fair in the heart and
lungs. The agreement between the two
readers for the overall image quality ratings
was excellent (κ = 1.0).
For the diagnostic image quality com-
parison with reference dedicated exams of
the same region, all studies of the abdomen
were rated as 4, and pelvis were rated as 3.
Chest, head and neck were rated as 2. No
studies were rated as 1 in any region. The
inter-observer agreement was excellent (κ
= 1.0). Figures 1–4 show representative
images illustrating the standard image qual-
ity of the sequences employed in this study.
DISCUSSION
Screening for major diseases through-
out the body has been of interest with im-
aging studies for at least a decade, follow-
ing the advent of faster imaging. The prob-
lem with most strategies for imaging
screening, is that the procedure itself may
be risky (whole-body CT, PET and PET/
CT) and also most approaches have had
limited ability to detect a full range of dis-
eases, since their protocols were individu-
ally dedicated to the evaluation of me-
tastases or vascular diseases(6–8,10,18–20).
In this study, a fast MR screening ap-
proach that screens for major disease catego-
ries of cancer, vascular, and degenerative/
inflammatory disease was developed. The
results show that using this protocol, im-
ages of the abdomen are of high diagnostic
Table 2 Checklist.
Cancer
Brain
Lungs
Liver
Pancreas
Kidneys
Esophagus, small bowel and colon
Rectum
Pelvic organs
Bone structures
Breast (female)
Vascular diseases
Intracranial vessels
Carotid arteries
Coronary arteries
Aorta and major branches origin
Hepatic portal system
Hepatic veins
Iliac veins
Superior vena cava, inferior vena cava
Inflammatory/degenerative
Brain
Heart
Lungs
Bone structures (spine, shoulder, joints and hip joints)
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Figure 1. Abdominal region. Coronal T2-weighted single-shot echo-train spin-echo without fat-suppression (A), axial T1-weighted 3D gradient-echo fat-sup-
pressed unenhanced (B), and gadolinium-enhanced on hepatic arterial dominant phase (C) and on interstitial phase (D).
A B
C D
Figure 2. Thoracic region. Gadolinium-enhanced T1-weighted 3D gradient-echo fat-suppressed coronal (A) and axial (C). T2-weighted single-shot echo-train
spin-echo without fat-suppression coronal (B) and fat-suppressed axial (D).
BA
C D
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quality in all subjects, therefore evaluation
of upper abdominal organs with this tech-
nique is optimally performed. The abdomen
was selected as the first region to be scanned
in order to acquire post-contrast hepatic
arterial dominant phase images(13), that is
the single most important abdominal data
set when using nonspecific extracellular
gadolinium chelate contrast agent(21). This
technique is essential for imaging the liver,
spleen, pancreas, and it provides useful
information on the kidneys, adrenals and
vessels. Therefore, the timing for this phase
of enhancement is the only timing for post-
contrast sequences that is crucial.
In the pelvis, sequences of lesser spatial
resolution were employed, especially the
T2-weighted sequences, compared to op-
timal dedicated MR pelvic studies(22). Op-
timal diagnostic quality T2-weighted se-
quences are performed with a 512 matrix
using a breathing averaged echo-train spin-
echo sequence, compared to the 256 matrix
of the single-shot T2-weighted echo-train
spin-echo in our study, and for this reason
pelvic studies were rated as 3 when com-
pared with reference dedicated exams. This
protocol is clearly not ideal for small co-
lonic polyps but may be of value for co-
lonic masses greater than 1.0 cm. All pel-
vic studies demonstrated consistent image
quality, which we anticipate that may be
adequate to screen for cancer, vascular and
degenerative/inflammatory diseases.
MRI of the lung has been limited in the
past because of long imaging times, mag-
netic susceptibility effects and motion ar-
tifacts. However, with faster sequences,
advanced hardware and high-field-strength
MR systems, the image quality has signifi-
cantly improved. The lack of ionizing ra-
diation exposure make MRI of the lungs
ideal for those who must undergo serial
imaging, pediatric patients, and as a poten-
tial screening tool, which is the aim of our
study. One of the sequences used in this
protocol was single-shot T2-weighted
echo-train spin-echo, since it is generally
motion insensitive, has little magnetic sus-
ceptibility or phase artifacts, and has been
documented to be useful for evaluating the
lung parenchyma(9,23,24). Gadolinium-en-
hanced images are also necessary for MR
assessment of the lungs. The 3D gradient-
echo T1-weighted sequence with fat sup-
pression used in this protocol show dimin-
ished phase artifact in the retrocardiac re-
gion in comparison to two-dimensional
gradient-echo T1-weighted images, allow-
ing for better evaluation of all portions of
the lung(14,17,25). The pulmonary vasculature
can also be evaluated with this sequence
because of its high spatial resolution, which
enables high-quality multiplanar recon-
struction. Additionally, gadolinium has a
larger window of visibility in the pulmo-
nary vessels than iodine on CT images,
rendering timing of data acquisition less
critical, what is particularly true with the
contrast agent employed (gadobenate
dimeglumine)(20). Inflammatory changes in
interstitial lung disease, mediastinal and
hilar adenopathy, and pulmonary nodules
can be evaluated with these two sequences
combined(26–31), especially with 3.0 T scan-
ners. Nodules as small as 4 mm can be seen
with MRI(28,30,32), and tiny nodules that are
missed on MR but seen on CT, are often
Figure 3. Pelvic region. Gadolinium-enhanced T1-weighted 3D gradient-echo fat-suppressed coronal (A) and axial (C). T2-weighted single-shot echo-train
spin-echo without fat-suppression sagittal (B) and fat-suppressed axial (D).
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calcified or scarred (fibrotic), showing low
proton density and low signal. The chest
studies were consistent in image quality,
but were rated as 2, using a priori knowl-
edge of CT as comparison because MRI
cannot yet depict interstitial lung disease or
detect smaller, 2 mm, nodules. However,
for the purposes of screening this protocol
may be sufficient.
The fat-suppressed 3D gradient-echo
sequences used for studying the head and
neck, are likely sufficient for mass lesion
and inflammatory disease detection, and
can be reformatted into different planes if
necessary. Less common and more subtle
diseases, such as multiple sclerosis plaques,
likely would require more sensitive se-
quences such as FLAIR(33), which was in-
cluded in our protocol and can also be used
for detecting and grading degenerative and
microvascular disease, combined with
single-shot echo-train spin-echo T2 se-
quence. Lauenstein et al.(9) reported on the
use of gadolinium-enhanced 3D gradient-
echo alone in the evaluation of the brain,
the addition of the FLAIR and T2-weighted
image sequences should provide more
complete diagnostic information than they
had described.
The neck and carotid arteries were in-
cluded in this study. The importance of
carotid artery disease was the major reason
for including the neck. Further optimiza-
tion may be needed.
Regarding the vascular system, large
and medium size vessels were adequately
evaluated with post-contrast 3D technique.
If the patient has symptomatic vascular
disease then it would not be a part of a
screening study, but would require a more
detailed MR angiographic protocol.
One limitation of this study is the small
and healthy study population and the result-
ing lack of targeted pathology. Thus it
should be considered a proof of concept
study. However, the sequences employed
here have been used for many years as the
core of dedicated high-resolution regional
protocols. Therefore, we anticipate that this
limitation reflects a truly disease-free pa-
tient population rather than a failure of the
protocol itself. The lesions detected dem-
onstrated the typical characteristics, con-
spicuity, and quality expected from these
sequences when used as part of a dedicated
high-resolution protocol. One potentially
more severe limitation of this study is the
lack of dedicated cardiac sequences, par-
ticularly in light of the fact that heart dis-
ease is the most common cause of mortal-
ity and morbidity(34). However, the se-
quences used in this protocol are sensitive
to vascular disease in general. It is reason-
able to expect that vascular disease in the
coronary arteries is likely to be correlated
with vascular disease elsewhere(35). This
screening protocol is not recommended for
patients with any specific indications of
heart disease, and a patient with such indi-
cation may require a follow-up with a dedi-
cated cardiac imaging exam.
This proof of concept study shown that
comprehensive whole-body MRI exams
can be performed in a less than 40-minute
period. Based on the experience of the pri-
mary investigator the completeness of di-
agnostic interrogation was considered as
follows. The abdominal sequences em-
ployed resulted in fully diagnostic studies.
Our technique of breast MRI was limited
because it did not include serial thin sec-
tion imaging to generate enhancement
curves. However it did show morphologi-
cal detail, which is important for breast
imaging(36) and also can reveal dilated veins
that have been reported as consistently
present in breast cancer(37). It should also
be feasible to add a more dedicated breast
MR study, including a second injection of
Figure 4. Head and neck regions. Gadolinium-enhanced T1-weighted 3D gradient-echo fat-suppressed
axial (A) and sagittal (C). Axial FLAIR (B) and sagittal T2-weighted single-shot echo-train spin-echo fat-
suppressed (D).
A B
C D
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gadolinium contrast. No dedicated cardiac
sequences were employed. Therefore, pa-
tients with suspected heart disease may
require a follow-up with dedicated cardiac
imaging exam. 3.0T MRI has been shown
to demonstrate 4 mm pulmonary nodules
consistently, which is sufficient for detec-
tion of primary cancer and also sufficient
for metastases. This protocol is likely not
effective for interstitial lung disease. For
patients with specific disease or a strong
suspicious, more detailed studies would be
required for: colon cancer, breast cancer
and coronary artery disease.
In summary, our preliminary results
show that a comprehensive whole-body
MRI study can be acquired in less than 40
minutes. Both for this study, and for other
whole-body screening approaches the
strengths and weaknesses should be ac-
knowledged and described to patients.
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